androstenediol
← Previous: androstatrienedione | 🏠 All Substances | 📊 Complete Table | Next: androstenedione →
OPSS Properties
| Classifications | 6000 |
| DEA Schedule | Schedule III |
| Reason | Controlled substance: Schedule III |
| Also Known As |
|
| Prohibited Because | DEA Controlled Substance List: Schedule III (DEA Controlled Substance List: Schedule III) WADA S1: Anabolic Agents (WADA Prohibited List S1: Anabolic Agents) |
| Added to Database | December 30, 2025 |
| Source Last Updated | May 28, 2024 |
| GUID | fb235258-dc93-45b9-b0f1-c57fe1ccae50 |
External Resources
- FDA UNII Search
- GSRS Full Record
- NCATS Inxight Drugs
- CAS Common Chemistry
- PubChem
- EPA CompTox Dashboard
UNII: 95PS51EMXY · CAS: 521-17-5
PubChem Properties
Chemical Structure
Interactive 3D Structure
| Molecular Formula | C19H30O2 |
| Molecular Weight | 290.4 g/mol |
| IUPAC Name | (3S,8R,9S,10R,13S,14S,17S)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol |
| InChIKey | QADHLRWLCPCEKT-LOVVWNRFSA-N |
📊 Complete Table | 🏠 All Substances
Substance 193 of 880